Table of Contents >> Show >> Hide
- What Cabometyx is (and what it treats)
- Cabometyx form and strengths
- Typical Cabometyx dosages by condition
- When to take Cabometyx (timing matters more than you’d think)
- What happens if you miss a dose?
- Cabometyx dose reductions and holds: very common, not a “failure”
- Drug interactions that can change Cabometyx dosing
- Special situations that affect “when to take” or whether to pause therapy
- Monitoring and side-effect management: what “dose-friendly” care looks like
- Frequently asked questions
- Conclusion
- Real-world experiences: what patients and caregivers often notice (and what helps)
Cabometyx (cabozantinib) is one of those cancer medicines that looks simple on the label“take once daily”and then immediately
gets real-life complicated once you factor in meals, side effects, other meds, and the fact that you are, in fact, a human being
who sometimes forgets things (like where you put your phone while holding your phone).
This guide breaks down Cabometyx strengths, the tablet form, the most common dosing schedules by diagnosis, how to take it correctly,
and what usually happens when side effects show up and the dose needs to change. It’s written for patients and caregivers, but it’s
detailed enough to help you have sharper conversations with your oncology team.
Important: This article is for education only, not medical advice. Always follow your prescriber’s instructions and the official Medication Guide.
What Cabometyx is (and what it treats)
Cabometyx is a brand-name form of cabozantinib, a targeted therapy (a “kinase inhibitor”) used for certain cancers.
In the U.S., Cabometyx tablets are used in adultsand in some cases pediatric patients ages 12 and olderfor specific cancers such as:
- Advanced renal cell carcinoma (RCC) (kidney cancer)
- Hepatocellular carcinoma (HCC) (liver cancer) after prior treatment with sorafenib
- Differentiated thyroid cancer (DTC) that is radioactive iodine–refractory/ineligible and has progressed after VEGFR-targeted therapy
- Well-differentiated neuroendocrine tumors (including pancreatic NET and extra-pancreatic NET) after prior treatment
Cabometyx vs. Cometriq: not interchangeable
This point is worth putting in big, friendly letters: Cabometyx tablets are not the same as cabozantinib capsules
(brand name Cometriq). They are used for different indications and have different dosing. Even though the active ingredient
shares a name, you should not substitute one for the other unless your oncology team explicitly directs it.
Cabometyx form and strengths
Cabometyx comes as an oral tablet in three strengths:
- 20 mg
- 40 mg
- 60 mg
Your prescription may use one strength tablet per day (for example, one 60 mg tablet daily), or it may use a different strength
based on your treatment plan and how your body tolerates therapy.
Typical Cabometyx dosages by condition
Cabometyx dosing depends on the cancer being treated, whether it’s combined with immunotherapy, and (for certain pediatric indications)
body weight. The “right” dose is the one your oncology team chooses for youbecause it accounts for your lab results, side effects,
other medications, and overall health.
Renal cell carcinoma (RCC): Cabometyx alone
A common starting dose for Cabometyx as a single agent in advanced RCC is:
- 60 mg by mouth once daily
Treatment often continues as long as it’s helping and side effects remain manageable.
Renal cell carcinoma (RCC): Cabometyx with nivolumab
When Cabometyx is used in combination with nivolumab (an immunotherapy), the Cabometyx tablet dose is commonly lower:
- 40 mg by mouth once daily (plus nivolumab on an infusion schedule)
Combination therapy can be very effective, but it also means side effects may come from either medicine (or the combo), so monitoring and
communication with your care team matter a lot.
Hepatocellular carcinoma (HCC)
For HCC (liver cancer) after sorafenib, Cabometyx is commonly prescribed as:
- 60 mg by mouth once daily
Differentiated thyroid cancer (DTC) and neuroendocrine tumors (NET)
For DTC and certain NETs (including pancreatic NET and extra-pancreatic NET) in adults and eligible pediatric patients (ages 12+),
dosing may be based on body weight:
- Body weight ≥ 40 kg: 60 mg by mouth once daily
- Body weight < 40 kg (pediatric): 40 mg by mouth once daily
When to take Cabometyx (timing matters more than you’d think)
Cabometyx is taken once per day. The key is taking it correctly with respect to food, because food can change how much
medicine your body absorbs.
Take Cabometyx on an empty stomach
The standard instruction is:
- Take Cabometyx at least 1 hour before eating or at least 2 hours after eating.
Pick a time you can actually stick to
The “best” time is usually the one that fits your routine and minimizes stomach/meal conflicts. Two common approaches:
- Morning strategy: Take it when you wake up, then delay breakfast by at least an hour.
- Evening strategy: Eat dinner earlier, wait at least 2 hours, then take Cabometyx before bed.
If your schedule changes (travel, holidays, infusion days, work shifts), it’s okay to ask your pharmacist or oncology nurse for help
building a practical timing plan. This is one of those situations where “small logistics” can seriously improve adherence.
How to take the tablet
- Swallow tablets whole. Do not crush, chew, or split.
- Take with water (a full glass is commonly recommended in patient education materials).
- Try to take it at the same time every day.
Foods and supplements to avoid
Certain foods and supplements can interfere with cabozantinib metabolism. A classic example is grapefruit:
- Avoid grapefruit and grapefruit juice.
- Avoid St. John’s wort (it may reduce cabozantinib levels).
What happens if you miss a dose?
If you miss a dose, the rule many patients are taught is the “12-hour rule”:
- If your next scheduled dose is more than 12 hours away, you may take the missed dose.
- If your next scheduled dose is less than 12 hours away, skip the missed dose and take your next dose at the regular time.
- Do not double up to “make up” for a missed dose.
Cabometyx dose reductions and holds: very common, not a “failure”
Many people need dose adjustments. This is normal with targeted therapies. The goal is not to “white-knuckle” a high doseit’s to find
a dose you can stay on consistently while still getting benefit.
When doctors may pause (withhold) Cabometyx
Prescribers often temporarily stop Cabometyx for side effects such as:
- Intolerable “moderate” symptoms that don’t improve with supportive care
- More severe side effects (for example, severe diarrhea, significant high blood pressure, serious bleeding concerns)
- Specific complications such as osteonecrosis of the jaw or wound-healing issues
Once symptoms improve, Cabometyx is frequently restarted at a lower dose.
Typical dose reduction “step-down” patterns
Dose reduction schedules vary by the starting regimen. Common step-down patterns include:
- From 60 mg daily: reduce to 40 mg daily, then to 20 mg daily if needed.
- From 40 mg daily (including combo with nivolumab): reduce to 20 mg daily, then to 20 mg every other day if needed.
- Pediatric patients < 40 kg starting at 40 mg daily: reduce to 20 mg daily, then 20 mg every other day if needed.
If the lowest dose still isn’t tolerable, your care team may recommend discontinuation or switching strategies. Again: this isn’t a moral
judgment. It’s oncologyyour body gets a vote.
Drug interactions that can change Cabometyx dosing
Cabozantinib is metabolized partly through pathways involving CYP3A4. Some medications can raise cabozantinib levels (increasing side-effect risk),
while others can lower levels (possibly reducing effectiveness). Your oncology team may:
- Lower the Cabometyx dose if you must take a strong CYP3A4 inhibitor.
- Increase the Cabometyx dose if you must take a strong or moderate CYP3A4 inducerbut there are limits to how high dosing can go.
Examples of medications to flag for your care team
Don’t self-edit your medication listjust bring it. But common “watch-list” examples include:
- Strong inhibitors (may increase levels): certain antifungals (like ketoconazole, itraconazole), some antibiotics (like clarithromycin), and some HIV antivirals.
- Inducers (may decrease levels): rifampin/rifabutin, certain seizure meds (like carbamazepine, phenytoin), and herbal supplements such as St. John’s wort.
Practical tip: if you see a new prescriber (urgent care, dentist, another specialist), tell them you’re on Cabometyx before you accept a new prescription.
Special situations that affect “when to take” or whether to pause therapy
Surgery and dental procedures
Cabometyx can increase bleeding risk and affect wound healing. Many patients are instructed to:
- Stop Cabometyx at least 3 weeks before planned surgery (including dental surgery or invasive dental procedures, depending on the situation).
- Wait at least 2 weeks after major surgery and until adequate wound healing before restarting (your surgeon/oncologist will guide the exact timing).
Hepatic (liver) impairment
Cabometyx dosing may need adjustment in moderate hepatic impairment, and it may be avoided in severe hepatic impairment.
If you have liver disease (separate from HCC), make sure your oncology team knows.
Pregnancy, contraception, and breastfeeding
Cabometyx can harm an unborn baby. If pregnancy is possible, your care team may recommend pregnancy testing before treatment and effective contraception during treatment
and for a period after the final dose. Breastfeeding is typically not recommended during treatment and for months after the last dose.
Monitoring and side-effect management: what “dose-friendly” care looks like
Cabometyx is often a long-game medication. The more proactive you are about side effects, the less likely you’ll be forced into a stop-and-start cycle.
Monitoring commonly includes checking blood pressure, lab work (including liver tests), and symptom tracking.
Side effects that frequently drive dose changes
- Diarrhea (can become dehydrating quickly)
- High blood pressure
- Hand-foot syndrome (palmar-plantar erythrodysesthesia: tenderness, redness, peeling, pain)
- Mouth sores and appetite changes
- Fatigue and weight loss
Concrete examples of “call your team sooner” moments
- You’re having diarrhea multiple times per day for more than a day, or you feel dizzy/dehydrated.
- Your blood pressure readings are consistently higher than your usual baseline.
- Foot pain makes it hard to walk normally, or hand pain makes daily tasks difficult.
- You notice unusual bleeding (vomiting blood, coughing blood, black/tarry stools) or severe abdominal pain.
These aren’t “bother your doctor” issuesthese are “help your doctor help you stay on treatment” issues.
Frequently asked questions
Can I take Cabometyx with food if it upsets my stomach?
Cabometyx is generally taken on an empty stomach because food can affect absorption. If nausea is a problem, ask your oncology team about anti-nausea strategies
that don’t involve taking Cabometyx with meals. Sometimes timing changes (morning vs. evening) help.
Can I split the tablet?
Cabometyx tablets are typically swallowed whole and are not meant to be split, crushed, or chewed. If swallowing is difficult, talk to your pharmacist and care team.
They may suggest techniques or evaluate alternatives rather than altering the tablet.
How long will I take Cabometyx?
Many people continue Cabometyx until the cancer progresses or side effects become unacceptable. Duration varies widely. Your oncology team will reassess regularly
using scans, labs, and symptom review.
Is 60 mg “better” than 40 mg?
Not automatically. The best dose is the one you can take consistently with manageable toxicity. A slightly lower daily dose you can maintain may outperform a higher dose
that forces frequent pauses.
Conclusion
Cabometyx dosing is built around a few core rules: it’s a once-daily tablet, it’s taken on an empty stomach, and the dose depends on the cancer being treated and whether it’s combined
with nivolumab. From there, real life takes overside effects, interactions, and procedures can all trigger dose holds or reductions.
The biggest practical win is consistency: choose a sustainable daily time, follow the empty-stomach instructions, keep a clean medication list, and report side effects early.
Cabometyx often works best when you and your care team treat dosing like a living plan, not a one-time decision.
Real-world experiences: what patients and caregivers often notice (and what helps)
People’s experiences with Cabometyx vary, but a few themes show up again and againespecially around routines and side effects that sneak up gradually. One of the first “aha” moments
many patients describe is that the medicine itself may be once daily, but the schedule feels like a small lifestyle renovation. Empty stomach timing becomes a daily puzzle:
“Do I take it early and push breakfast back?” or “Do I eat dinner earlier and take it at night?” A lot of patients land on the option that causes the least friction. In practice,
the “best” plan is the one you can follow on tired days, busy days, and days when your calendar is basically a prank.
Another common experience: side effects often arrive like uninvited guests who don’t knockthey just appear and start rearranging the furniture. Diarrhea is a frequent complaint,
and many patients learn quickly that waiting it out can backfire. Having a clear plan (what to take, how much to hydrate, when to call the clinic) can prevent dehydration and reduce
the chances of a forced treatment pause. Caregivers often mention that keeping a simple symptom log helps: number of bowel movements, blood pressure readings, appetite, and foot/hand pain.
It’s not glamorous, but it turns vague discomfort into actionable information your oncology team can use.
Hand-foot syndrome is another “real life” issue people talk about. Patients may notice tenderness firstlike their feet are mad at them for existingthen redness, peeling, or pain.
Practical tweaks can make a big difference: supportive shoes, soft socks, avoiding very hot showers, and moisturizing consistently (especially after washing hands). Some people switch to
gentler household routines for a whileless scrubbing, fewer long walks on hard pavementbecause protecting your skin can help you stay on therapy. The goal isn’t to stop living; it’s to
remove avoidable triggers while your body adjusts.
Fatigue is often described as “not sleepiness, more like my batteries won’t charge to 100%.” Patients sometimes do better with pacing: short walks instead of long workouts, planned rest
breaks, and asking for help with errands during tougher weeks. Appetite changes and taste changes can also pop up. Some patients do better with small, protein-forward snacks (timed so they
don’t interfere with the empty-stomach rule), and many learn that “eat what sounds tolerable” is a valid strategy when you’re trying to maintain weight.
Probably the most encouraging shared experience is this: dose changes are common and often helpful. People sometimes worry that a reduction means the treatment “isn’t working,” but in
many real-world stories, lowering the dose (or briefly holding it) is exactly what allows someone to stay on Cabometyx longer and with a better quality of life. If there’s one mindset
that seems to help, it’s treating side-effect management like a collaborationbring your symptoms early, bring your med list, and let the team adjust the plan. In cancer care, “toughing it out”
isn’t always the hero move. Sometimes the hero move is setting an alarm, drinking water, putting on comfy shoes, and calling the clinic before a manageable side effect becomes a crisis.
